Establishment of a Predictive System for Perioperative Risk Assessment and Electronic Flowcharting Response Strategies in Thoracic Surgery

NCT06566053 | Enrolling By Invitation

• 1 other identifier: LYF2023105
• Study Type: observational
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

1. 1.To establish a risk assessment scale for thoracic surgery for the Chinese population, and to classify patients; risk according to the relevant scale;
2. 2.Combining the guidelines for the management of acute and critical illnesses in thoracic surgical care units and the characteristics of diagnosis and treatment operations, to make an AI-assisted diagnosis and treatment process software;
3. 3.Evaluate whether the software can provide timely and correct diagnosis and treatment recommendations for critically ill patients, shorten the time for homogenized training of specialist intensivists, and reduce the hospitalization cost of patients under the review of resident training instructors of various specialties.

Conditions

Perioperative Complications

Outcome Measures

Primary Outcomes (1)

• Acute Respiratory Distress Syndrome

  ARDS definition was based on the new global definition of ARDS10. Briefly, intubated ARDS was defined as an oxygenation index of less than 300 under a positive end-expiratory pressure (PEEP) of at least 5 cmH2O, and non-intubated ARDS was defined as patients receiving high-flow nasal oxygen (HFNO) ≥ 30 L/min or noninvasive ventilation/continuous positive airway pressure (NIV/CPAP) with a PEEP of at least 5 cmH2O and meeting PaO2:FiO2 ≤ 300 mm Hg or SpO2:FiO2 ≤ 315 (if SpO2 ≤ 97%).

  2024.8-2024.12

Secondary Outcomes (6)

• In hospital mortality

  2024.8-2024.12

• Length of hospital stay

  2024.8-2024.12

• Length of ICU stay

  2024.8-2024.12

• Length of postoperative stay

  2024.8-2024.12

• Duration of mechanical ventilation

  2024.8-2024.12

Study Arms (1)

Patients who underwent thoracic surgery

Gender:Both Participant age:18-100 Examples include early-stage non-small cell lung cancer (NSCLC), NSCLC patients who have undergone neoadjuvant therapy, esophageal diseases, mediastinal masses, chest wall disorders, and other related conditions.

Other: Observation

Interventions

Observation OTHER

Observation

Patients who underwent thoracic surgery

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients admitted to the Department of Thoracic Surgery of the Second Xiangya Hospital of Central South University for surgical treatment.

You may qualify if:

• Patients admitted to the Department of Thoracic Surgery of the Second Xiangya Hospital of Central South University for surgical treatment.

You may not qualify if:

• Patients admitted to the Department of Thoracic Surgery of the Second Xiangya Hospital of Central South University without surgical treatment.
• Patients under the age of 18.

Sponsors & Collaborators

• Hengxing Liang: lead
• Changsha Xinghong Network Technology Co.: collaborator

Study Sites (1)

the Second Xiangya Hospital of Central South University

Changsha, Hunan, 410011, China

Location

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

Methods; Investigative Techniques

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Associate professor

Study Record Dates

• First Submitted: May 26, 2024
• First Posted: August 22, 2024
• Study Start: July 1, 2023
• Primary Completion: December 31, 2024
• Study Completion (Estimated): July 1, 2027
• Last Updated: August 22, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will share

Locations

CN (1)